Emmessar Biotech Share Price Today | Stock Price & Emmessar Biotech Share Screener
As of November 18, 2026, the live Emmessar Biotech share price (BSE: EMMESSA) is ₹27.60, down 2.78% from the previous close, with shares trading between ₹27.60 and ₹28.80 in today's trading session, and a 52-week range of ₹19.99–₹32.35. Track Emmessar Biotech networth to gauge the company's total market size. Use the Emmessar Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Emmessar Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Emmessar Biotech Share Price Chart
Track the current stock price of Emmessar Biotech with an interactive chart. Analyse EMMESSA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Emmessar Biotech stock quote in one place.
The quote of ₹27.60 sits between the 52-week low of ₹19.99 and the 52-week high of ₹32.35, and the latest session moved -2.78% from the previous close.
Emmessar Biotech Company Profile - Fundamental Screener
Screen Emmessar Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for EMMESSA shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Chemicals & Petrochemicals industry, and it trades under ISIN INE634B01016.
Company Details
Classification
Identifiers and Leadership
Emmessar Biotech Balance Sheet Screener
Screen EMMESSA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹10, up from ₹9 in 2025.
Latest statistics put total assets at ₹10 and shareholder funds at ₹8.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 10 | 9 | 9 | 8 | 7 | 8 | 6 | 5 | 4 | 3 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 8 | 8 | 7 | 7 | 6 | 6 | 4 | 4 | 3 | 2 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 3 | 3 | 2 | 2 | 1 | 1 | -1 | -2 | -2 | -3 |
Emmessar Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Emmessar Biotech income statement and profit fundamentals. Analyze EMMESSA quarterly results. Emmessar Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹2 and net profit was ₹0, equal to earnings per unit of ₹0.80, at an operating margin of -416%.
In that period expenses were ₹2, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹2 and net profit of ₹0.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 2 | 2 | 3 | 3 | 3 | 2 | 9 | 5 | 2 | 3 | 4 | 2 | 2 |
| Expenses | 2 | 2 | 2 | 2 | 2 | 1 | 6 | 4 | 1 | 2 | 2 | 2 | 2 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
| Operating Profit % | -416.00% | -365.00% | -156.00% | -195.00% | -68.00% | -245.00% | 12.00% | -12.00% | -102.00% | -32.00% | 9.00% | 1.00% | -7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | -1 | 0 |
| Tax | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -1 | 0 |
| EPS | 0.80 | 0.87 | 0.63 | 1.50 | 0.99 | 0.94 | 2.90 | 1.51 | 1.05 | 1.83 | 2.36 | -0.93 | -0.24 |
Emmessar Biotech Cash Flow Screener - Liquidity Fundamentals
Screen EMMESSA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹0.
Over the same period, investing activities provided ₹0 and financing activities provided ₹0.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 0 | 0 | 1 | 0 | 2 | 1 | 1 | 0 | 1 | 1 |
| Investing Activities | 0 | 0 | -1 | -1 | -3 | 0 | -1 | 0 | -1 | -1 |
Financing and Net Cash | ||||||||||
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Emmessar Biotech Shareholding Pattern Screener
See Emmessar Biotech shareholding pattern with promoter, FII, and DII holdings. Check Emmessar Biotech promoter holding and ownership changes for EMMESSA on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 59.53%, foreign institutions 0.00%, domestic institutions 0.20% and the public 38.07%, spread across 7,172 shareholders.
The shareholder count was 7,172 in 2026-Mar, compared with 7,136 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 38.07% | 38.07% | 38.07% | 37.15% | 37.14% | 38.12% | 38.09% | 37.94% |
| Other Holding | 2.21% | 2.21% | 2.21% | 3.12% | 3.14% | 2.16% | 2.19% | 2.33% |
| Shareholder Count | 7,172 | 7,136 | 7,144 | 7,180 | 7,173 | 7,350 | 7,244 | 7,146 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Emmessar Biotech. Emmessar Biotech dividend yield can be compared with peers and other stocks in the market.
Emmessar Biotech Stock Index Membership - Nifty & Sensex
See which indices include Emmessar Biotech stock. Check EMMESSA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Emmessar Biotech Market Events Screener - Corporate Actions
Get Emmessar Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Emmessar Biotech stock events that may affect EMMESSA share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 31, 2026, with a record date of October 31, 2026.
It is followed by Annual General Meeting dated September 29, 2026 and Quarterly Result Announcement dated August 7, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-10-31 | 2026-10-31 | Quarterly Result Announcement | NA | 5.87% |
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -10.83% |
| 2026-08-07 | 2026-08-07 | Quarterly Result Announcement | NA | 0.24% |
| 2026-05-12 | 2026-05-12 | Quarterly Result Announcement | NA | 2.94% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 2.14% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.36% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | 23.37% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -4.34% |
| 2025-04-24 | 2025-04-24 | Quarterly Result Announcement | NA | 6.06% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 7.24% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 43.67% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | 7.42% |
Emmessar Biotech Competitors Screener - Peer Stocks Comparison
Screen EMMESSA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Solar Industries | 174,990 | 74.20 | 9,966 | 30.94% | 1,737 | 50.71 |
| Pidilite Industries | 155,298 | 57.30 | 14,867 | 11.05% | 2,471 | 50.46 |
| SRF | 73,365 | 32.10 | 15,894 | 7.20% | 1,835 | 53.97 |
| Linde | 58,424 | 118.20 | 2,549 | -0.17% | 549 | 69.72 |
| Gujarat Fluorochemicals | 51,762 | 78.30 | 5,126 | 5.63% | 574 | 58.93 |
| Navin Fluorine International | 51,303 | 56.50 | 3,379 | 41.21% | 664 | 75.55 |
| Aether Industries | 22,261 | 89.20 | 1,181 | 34.17% | 220 | 58.26 |
| Deepak Nitrite | 21,747 | 20.50 | 7,947 | -5.01% | 551 | 55.38 |
| Aarti Industries | 17,475 | 29.50 | 8,291 | 13.78% | 419 | 59.07 |
| Fine Organic Industries | 16,248 | 33.80 | 2,483 | 4.89% | 417 | 54.16 |
Emmessar Biotech Company Announcements - News & Reports Screener
Screen EMMESSA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 2, 2026.
The next most recent announcements are dated October 31, 2026 and October 31, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-02 | Newspaper Add | - |
| 2026-10-31 | Financial Results For 30Th September 2026. | - |
| 2026-10-31 | Board Meeting Outcome for For Unaudited Financial Results For Period Ending 30/09/2026 | - |
| 2026-10-23 | Board Meeting Intimation for Unaudited Results For The Quarter Ended September 30 2026 | - |
| 2026-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-10-02 | Newapaper Add For Relodgment Of Shares | - |
| 2026-09-29 | Closure of Trading Window | - |
| 2026-09-29 | Scutinizers Report | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-05 | Newspaper Add | - |
| 2026-09-04 | Communication To Shareholders Whose Email Ids Are Not Registered | - |
| 2026-09-04 | Communication Sent To Shareholders Holding Physical Shares | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Notice Of The 34Th Annnual General Meeting Of The Company To Be Held On September 29 2026 | - |
| 2026-08-27 | Newspaper Add For AGM | - |
| 2026-08-08 | Newapaper Add | - |
| 2026-08-07 | Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-07 | Board Meeting Outcome for For Unaudited Financial Results For The Quarter Ending June 30 2026 | - |
| 2026-08-01 | Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-01 | Newspaper Add For Relodgement Of Shares | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹27.60, within a 52-week range of ₹19.99 to ₹32.35. The P/E ratio is 30.90 and the P/B ratio is 1.55, with earnings per unit of ₹0.87. Market capitalisation stands at ₹13.00 Cr. The company operates in the Chemicals sector, in the Chemicals & Petrochemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.